Trial Profile
Phase I Clinical Trial to Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Feb 2020
Price :
$35
*
At a glance
- Drugs Germinal peptide (Primary)
- Indications Corneal disorders
- Focus Adverse reactions
- Sponsors Lee's Pharmaceutical; Zhaoke Pharmaceutical (Hefei)
- 31 Jan 2020 Status changed from not yet recruiting to completed.
- 19 Sep 2018 New trial record